Been lurking in c/hplc for about 3 months and finally have something worth posting. Short version: week 49, 5mg, and oral GLP-1 is the bit I still cannot get a straight…
u/marit_sandvik
Contributes reviews on supplier material. Based in Essen.
member · joined 14 May 2025
Overview — page 2 of 5
comment on is it normal to get injection-site soreness at week 10 in c/glp1uk · 320 points · 1 months ago
price posts need the date — UK pricing moves monthly
comment on [PSA] ATTAIN is not what most of this community thinks it is in c/orforglipron · 2 points · 1 months ago
availability speculation must be flaired Speculation
comment on [Meta] the small molecule rule is doing its job and people should stop complaining in c/orforglipron · 121 points · 2 months ago
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
comment on my TSH moved and I cannot work out whether stopped is why in c/darkspot · 21 points · 2 months ago
still evidence-based: what went wrong, when, proof
comment on someone explain pharmacy to me like I have not read a paper in years in c/glp1uk · 9 points · 2 months ago
Boots stock is hit-and-miss by location
comment on vendor vs testing — genuinely asking which matters more in c/vendorvetting · 42 points · 2 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on transit time — 15 things I got wrong before I got it right in c/intlshipping · 4 points · 2 months ago
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · 1 points · 2 months ago
The early fullness was genuinely awful for three weeks and then simply stopped.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · -20 points · 2 months ago
The early fullness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · 1 points · 2 months ago
The fatigue was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
comment on what would you tell week-1 you about what went wrong in c/darkspot · 38 points · 4 months ago
money lost to group buys
comment on [Meta] proposal — a flair for small molecule posts in c/orforglipron · 1 points · 4 months ago
cite ATTAIN/ACHIEVE arms specifically
comment on genuine question about pricing that I am slightly embarrassed to ask in c/glp1uk · 235 points · 4 months ago
no naming online pharmacies that prescribe without a consultation
comment on tried stopped for 3 weeks. here is what happened. in c/darkspot · 2 points · 4 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on [PSA] tier 3 is not what most of this community thinks it is in c/glp1uk · 16 points · 4 months ago
Strongly agree. MHRA is region-specific.
comment on [PSA] tier 3 is not what most of this community thinks it is in c/glp1uk · 28 points · 4 months ago
Boots stock check: called 11 locations in France, 38 had 0.5mg in stock. Regional variation is real.
comment on [PSA] tier 3 is not what most of this community thinks it is in c/glp1uk · 5 points · 4 months ago
price posts need the date — UK pricing moves monthly
Right, the NHS question again, but with numbers this time. I have 21 data points over 8 weeks. The pattern is consistent enough that I do not think it is chance, and…
comment on [PSA] EMS is not what most of this community thinks it is in c/intlshipping · 65 points · 5 months ago
packaging quality matters on the 9-hour segments